Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ishida

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Hematology|November 2, 2019
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysisKazuhito Suzuki, Nobuhiro Tsukada, Noriko Nishimura, et al.
Clinical Neurology and Neurosurgery|February 15, 2020
Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosisKazuto Katsuse, Kaho Akiyama, Tadao Ishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2020
[Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study]Mizuki Ogura, Nobuhiro Tsukada, Takao Yogo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2023
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy]Yuka Norihama, Moe Nomura, Yuki Oda, et al.
Microbiology and Immunology|June 5, 2009
Occurrence of the African subgroup (Ia) of BK polyomavirus in younger Japanese childrenKaori Tanaka, Tsukasa Hori, Naoki Hatakeyama, et al.
Cancer Science|January 17, 2017
Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in JapanKenshi Suzuki, Masaki Ri, Takaaki Chou, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients]Yumiko Yoshiki, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
Journal of Medical Virology|December 2, 2008
Quantification of BK polyoma viruria in Japanese children and adults with hemorrhagic cystitis complicating stem cell transplantationKaori Tanaka, Tsukasa Hori, Naoki Hatakeyama, et al.
Ejhaem|April 8, 2026
Treatment Discontinuation After Achieving MRD Negativity in Multiple Myeloma in the Pre-BCMA Era: A Prospective, Single-Centre StudyKota Sato, Kenshi Suzuki, Shotaro Sugita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Efficacy of plerixafor in autologous peripheral blood stem cell collection]Takao Yogo, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Hematology|November 2, 2019
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysisKazuhito Suzuki, Nobuhiro Tsukada, Noriko Nishimura, et al.
Clinical Neurology and Neurosurgery|February 15, 2020
Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosisKazuto Katsuse, Kaho Akiyama, Tadao Ishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2020
[Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study]Mizuki Ogura, Nobuhiro Tsukada, Takao Yogo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2023
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy]Yuka Norihama, Moe Nomura, Yuki Oda, et al.
Microbiology and Immunology|June 5, 2009
Occurrence of the African subgroup (Ia) of BK polyomavirus in younger Japanese childrenKaori Tanaka, Tsukasa Hori, Naoki Hatakeyama, et al.
Cancer Science|January 17, 2017
Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in JapanKenshi Suzuki, Masaki Ri, Takaaki Chou, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients]Yumiko Yoshiki, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
Journal of Medical Virology|December 2, 2008
Quantification of BK polyoma viruria in Japanese children and adults with hemorrhagic cystitis complicating stem cell transplantationKaori Tanaka, Tsukasa Hori, Naoki Hatakeyama, et al.
Ejhaem|April 8, 2026
Treatment Discontinuation After Achieving MRD Negativity in Multiple Myeloma in the Pre-BCMA Era: A Prospective, Single-Centre StudyKota Sato, Kenshi Suzuki, Shotaro Sugita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Efficacy of plerixafor in autologous peripheral blood stem cell collection]Takao Yogo, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
Pageof 16